Key Financial Inc’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $161K | Hold |
307
| – | – | 0.03% | 311 |
|
|
2025
Q1 | $195K | Hold |
307
| – | – | 0.04% | 270 |
|
|
2024
Q4 | $219K | Hold |
307
| – | – | 0.05% | 241 |
|
|
2024
Q3 | $323K | Buy |
307
+1
| +0.3% | +$1.05K | 0.07% | 200 |
|
|
2024
Q2 | $322K | Hold |
306
| – | – | 0.08% | 185 |
|
|
2024
Q1 | $295K | Hold |
306
| – | – | 0.08% | 187 |
|
|
2023
Q4 | $269K | Hold |
306
| – | – | 0.07% | 188 |
|
|
2023
Q3 | $252K | Hold |
306
| – | – | 0.08% | 179 |
|
|
2023
Q2 | $220K | Buy |
306
+35
| +13% | +$25.1K | 0.07% | 197 |
|
|
2023
Q1 | $223K | Buy |
271
+195
| +257% | +$160K | 0.08% | 183 |
|
|
2022
Q4 | $52.4K | Hold |
76
| – | – | 0.02% | 351 |
|
|
2022
Q3 | $52K | Hold |
76
| – | – | 0.02% | 355 |
|
|
2022
Q2 | $45K | Hold |
76
| – | – | 0.02% | 381 |
|
|
2022
Q1 | $53K | Buy |
76
+71
| +1,420% | +$49.5K | 0.03% | 354 |
|
|
2021
Q4 | $3K | Buy |
+5
| New | +$3K | ﹤0.01% | 791 |
|
|
2020
Q2 | – | Sell |
-105
| Closed | -$50K | – | 501 |
|
|
2020
Q1 | $50K | Buy |
+105
| New | +$50K | 0.05% | 212 |
|